XML 21 R6.htm IDEA: XBRL DOCUMENT v3.7.0.1
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Millions
 12 Months Ended
Apr. 01, 2017
Apr. 02, 2016
Mar. 28, 2015
Cash flows from operating activities      
Net income $ 551.5 $ 837.7 $ 881.0
Adjustments to reconcile net income to net cash provided by operating activities:      
Depreciation and amortization 219.8 183.2 138.4
Equity compensation expense 33.9 48.4 48.9
Deferred income taxes (60.3) (1.9) 6.2
Non-cash litigation related costs 0.0 1.9 5.7
Amortization of deferred rent 9.2 2.6 5.1
Loss on disposal of fixed assets 3.4 2.8 1.9
Impairment of long-lived assets 199.2 10.9 0.8
Amortization of deferred financing costs 0.9 0.9 0.7
Tax benefits on exercise of share options (6.6) (21.1) (45.3)
Foreign currency losses (gains) 2.6 4.8 (1.5)
Gain on acquisition of MK Korea 0.0 (3.7) 0.0
Loss (income) earned on joint venture 0.0 1.0 (0.1)
Change in assets and liabilities:      
Receivables, net 59.6 52.5 (83.3)
Inventories 20.6 (16.3) (112.4)
Prepaid expenses and other current assets (0.9) (5.3) (20.1)
Other assets (7.9) (0.4) (6.3)
Accounts payable 37.5 14.2 (8.6)
Accrued expenses and other current liabilities (61.0) 104.5 36.3
Other long-term liabilities 26.5 11.7 10.5
Net cash provided by operating activities 1,028.0 1,228.4 857.9
Cash flows from investing activities      
Capital expenditures (164.8) (369.2) (356.2)
Purchase of intangible assets (5.5) (11.4) (29.2)
Investment in joint venture 0.0 (1.0) (3.0)
Cash paid for business acquisition, net of cash acquired (480.6) 0.5 0.0
Net cash used in investing activities (650.9) (381.1) (388.4)
Cash flows from financing activities      
Repurchase of treasury shares (1,004.8) (1,152.4) (495.3)
Tax benefits on exercise of share options 6.6 21.1 45.3
Exercise of employee share options 8.4 12.7 15.3
Repayments under revolving credit agreement (1,093.8) (199.8) 0.0
Borrowings under revolving credit agreement 1,240.0 192.6 0.0
Payment of deferred financing costs 0.0 (2.4) 0.0
Other financing activities 0.0 (0.1) 0.0
Net cash used in financing activities (843.6) (1,128.3) (434.7)
Effect of exchange rate changes on cash and cash equivalents (5.9) 4.1 (27.1)
Net (decrease) increase in cash and cash equivalents (472.4) (276.9) 7.7
Beginning of period 702.0 978.9 971.2
End of period (including restricted cash of $1.9 million at April 1, 2017) 229.6 702.0 978.9
Supplemental disclosures of cash flow information      
Cash paid for interest 3.5 1.5 0.7
Cash paid for income taxes 171.1 273.0 373.3
Supplemental disclosure of noncash investing and financing activities      
Accrued capital expenditures $ 22.8 $ 33.6 $ 32.9